SP TRIO D FORTE TABLET

Product Description

Product Name: SP TRIO D FORTE TABLET
Composition: Sitagliptin 100mg + Dapagliflozin 10mg + Metformin 1000mg (ER)

Product Description for Trade India & B2B Platforms:

SP TRIO D FORTE TABLET is a powerful triple-combination therapy formulated with Sitagliptin 100mg, Dapagliflozin 10mg, and Metformin 1000mg (Extended Release) for advanced management of Type 2 Diabetes Mellitus. Designed for patients requiring comprehensive glycemic control, this high-strength formulation offers multi-mechanism efficacy in a single convenient dose. Ideal for pharmaceutical distributors, bulk buyers, and retailers, SP TRIO D FORTE meets growing demand in the diabetic care segment.

Key Benefits:

• Triple-Action Therapy:
  Sitagliptin enhances insulin secretion (DPP-4 inhibitor)
  Dapagliflozin promotes glucose excretion via kidneys (SGLT2 inhibitor)
  Metformin (ER) improves insulin sensitivity and reduces hepatic glucose output

• Effective HbA1c Reduction: Targets fasting and postprandial blood sugar levels.

• Extended Release Metformin: Ensures better GI tolerance and sustained effect.

• Cardio-Renal Benefits: Dapagliflozin supports cardiovascular and renal protection.

Usage/Application:

• Indicated for adults with Type 2 Diabetes Mellitus not adequately controlled with dual therapy.

• Typically prescribed for long-term diabetes management under medical supervision.

• Administered once daily with meals to optimize effectiveness and tolerability.

Why Choose SP TRIO D FORTE:

• High-potency triple therapy in one tablet for better patient compliance.

• Manufactured in WHO-GMP certified facilities for global quality standards.

• Available in bulk quantities, ideal for hospital supply, large pharmacies, and B2B distribution.

• Private labeling and custom packaging options available